Dermatology pp 899-912 | Cite as


  • Otto Braun-Falco
  • Gerd Plewig
  • Helmut H. Wolff
  • Richard K. Winkelmann


Porphyrias are rare inborn or acquired diseases related to disorders in heme biosynthesis. This type of defect takes various clinical forms characterized by elevated contents of certain porphyrins or their precursors in the tissues, and urine, or stool. The porphyrins are light-sensitizing (phototoxic) substances, and disorders related to them result in phototoxic symptoms in skin areas exposed to light. Only acute intermittent porphyria is an exception. The genetically conditioned biochemical anomaly is not obvious in some patients, one therefore speaks of latent porphyria. In such cases the disease is sometimes made manifest by provocation, e.g., by drugs such as chloroquine, griseofulvin, or oral contraceptives, as well as by chemicals, environmental pollutants, or heavy metals.


Porphyria erythropoietica congenita Günther’s disease congenital porphyria. Protoporphyria erythropoietica etythrohepatic protoporphyria protoporphyrinemic light dermatosis. Porphyria acuta intermittens porphyria hepatica acuta. Porphyria vaiegata hereditary pootoco-proproporphyria mixed hepatic porphyria South African genetic porphyria. Porphyria hepatica chronica chronic porphyria syndrome actinic-traumatic bullous porphyrin dermatosis(Tappeiner 1953) porphyria bullosa congenita tarda. Porphyria hepatoerythrocytaria erythropoietic porphyrin-hepatitis. 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bickers DR (1986) Porphyria. Dermatol Clin 4:277–290 Bickers DR, Pathak MA (1987) The porphyrias. In: Fitzpatrick TB, Eisen AZ, Wolff K et al. (eds) Dermatology in general medicine, 3th edn. McGraw-Hill, New York, pp 1666–1715Google Scholar
  2. Cripps DJ, Peters HA (1967) Fluorescing erythrocytes and porphyrin screening test on urine, stool, and blood. Arch Dermatol 96: 712–720PubMedCrossRefGoogle Scholar
  3. Disler PB, Blekkenhorst GH, Eales L (1984) The biochemical diagnosis of porphyria. Int J Dermatol 23: 2–10PubMedCrossRefGoogle Scholar
  4. Doss M (ed) (1978) Diagnosis and therapy of porphyries and lead intoxication. Springer, BerlinGoogle Scholar
  5. Elder GH (1983) Recent advances in the identification of enzyme deficiencies in the porphyrias. Br J Dermatol 108: 729–734PubMedCrossRefGoogle Scholar
  6. Goerz G, Teikemeier G, Strohmeyer G (1987) Die Prophyrien. Intern Welt 7: 173–180Google Scholar
  7. Goldberg A, McColl KEL (1978) The porphyrias. Medicine (Baltimore) 11: 551–555Google Scholar
  8. Ippen H (1984) Die Prophyrinkrankheiten. In: Bock HE, Gerock W, Hartmann F (eds) Klinik der Gegenwart, vol 6. Urban and Schwarzenberg, Munich, pp 209–227Google Scholar
  9. Kappas A, Sassa S, Galbraith RA et al. (1989) The porphyrias. In: Scriver CR, Beaudet AL, Sly WS et al. (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp 1305–1365Google Scholar
  10. Poh-Fitzpatrick MB (1986) Molecular and cellular mechanism of porphyrin photosensitization. Photodermatol 3: 148–157PubMedGoogle Scholar
  11. Rimington C (1985) A review of the enzymic errors in the various porphyrias. Scand J Clin Lab Invest 45:291–301 Rorsman H, Harber LC (eds) (1982) Cutaneous porphyrias. Acta Derm Venereol (Stockh) Suppl 100: 1–131CrossRefGoogle Scholar
  12. Sassa S, Kappas S (1981) Genetic, metabolic, and biochemical aspects of the porphyrias. Adv Hum Genet 11: 121–231PubMedGoogle Scholar
  13. Tschudy DP, Lamon JM (1980) Porphyrin metabolism and the porphyrias. In: Bondy PK, Rosenberg LE (eds) Dun-can’s disease of metabolism, 8th edn. Saunders, Philadelphia, p 939Google Scholar
  14. Watson DJ, Schwartz S (1941) A simple test for urinary porphobilinogen. Proc Soc Exp Biol Med 47: 393CrossRefGoogle Scholar
  15. Deybach JC, Grandchamp B, Grelier M et al. (1980) Prenatal exclusion of congenital erythropoietic porphyria ( Günther’s disease) in a fetus at risk. Hum Genet 53: 217–221Google Scholar
  16. Günther H (1911) Die Hämatoporphyrie. Dtsch Arch Klin Med 105: 89–146Google Scholar
  17. Ippen H, Fuchs T (1980) Porphyria erythropoietica Günther. Clin Haematol 323–344Google Scholar
  18. Kushner JP, Pimstone NR, Kjeldsberg CR et al. (1982) Congenital erythropoietic porphyria, diminished activity of uroporphyrinogen decarboxylase and dyserythropoiesis. Blood 59: 726–737Google Scholar
  19. Nordmann Y, Deybach JC (1986) Congenital erythropoietic porphyria. Semin Dermatol 5: 106–114Google Scholar
  20. Poh-Fitzpatrick MB (1986) The erythropoietic porphyrias. Dermatol Clin 4: 291–300PubMedGoogle Scholar
  21. Stretcher GS (1977) Erythropoietic porphyria. Two cases and the results of metabolic alkalization. Arch Dermatol 113: 1553–1557PubMedCrossRefGoogle Scholar
  22. Anton-Lamprecht I, Meyer B (1970) Zur Ultrastruktur der Haut bei Protoporphyrinämie. Dermatologica 141: 76–83PubMedCrossRefGoogle Scholar
  23. Baart de la Faille H, Suurmond D, Went LN et al. (1972) ß-Carotene as a treatment for photohypersensitivity due to erythropoietic protoporphyria. Dermatologica 145: 389–394Google Scholar
  24. Bloomer JR (1979) Pathogenesis and therapy of liver disease in protoporphyria. Yale J Biol Med 52: 39–48PubMedGoogle Scholar
  25. Bonkowski HH, Schned AR (1986) Fatal liver failure in protoporphyria. Gastroenterology 90: 191–201Google Scholar
  26. Braun-Falco O, Burg G, Schmidt D (1970) Protoporphyrinämische Lichtdermatose vom Typ des Quinckeschen Ödems. Munch Med Wochenschr 112: 1443–1447PubMedGoogle Scholar
  27. Cripps DJ, Goldfarb SS (1978) Erythropoietic protopor- phyria: hepatic cirrhosis. Br J Dermatol 98: 349–354PubMedCrossRefGoogle Scholar
  28. DeLeo VA, Poh-Fitzpatrick M, Mathews-Roth M et al. (1976) Erythropoietic protoporphyria. 10 years’ experience. Am J Med 60: 8–22PubMedCrossRefGoogle Scholar
  29. Gigli I, Schothorst AA, Soter NA (1980) Erythropoietic protoporphyria. Photoactivation of the complement system. J Clin Invest 66: 517–522Google Scholar
  30. Gschnait FG, Wolff K, Konrad K (1975) Erythropoietic protoporphyria — submicroscopic events during the acute photosensitivity flare. Br J Dermatol 92: 545–557CrossRefGoogle Scholar
  31. Mathews-Roth MM (1977) Erythropoietic protoporphyria, diagnosis and treatment. N Engl J Med 297: 98–100PubMedCrossRefGoogle Scholar
  32. Poh-Fitzpatrick MB (1986) Erythropoietic protoporphyria. Semin Dermatol 5: 99–105Google Scholar
  33. Ryan EA, Madill GT (1968) Electron microscopy of the skin in erythropoietic protoporphyria. Br J Dermatol 80: 561–570PubMedCrossRefGoogle Scholar
  34. Doss MO (1982) Hepatic porphyrias: pathobiochemical, diagnostic, and therapeutic implications. Prog Liver Dis 7: 573–597PubMedGoogle Scholar
  35. Lehr PA, Doss M (1981) Chronic hepatic porphyria with uroporphyrinogen decarboxylase defect in four generations. Dtsch Med Wochenschr 196: 241–245CrossRefGoogle Scholar
  36. Romeo G (1980) The hepatic prophyrias. Prog Med 4: 169–197Google Scholar
  37. Smith AG, DeMatteis F (1980) Drugs and the hepatic porphyrias. Clin Hematol 9: 399–425Google Scholar
  38. Felsher BJ, Redeker AG (1967) Acute intermittent porphyria. Effect of diet and griseofulvin. Medicine (Baltimore) 46: 217–228Google Scholar
  39. Goldberg A (1985) Molecular genetics of acute intermittent porphyria. Br Med J 291: 499–500CrossRefGoogle Scholar
  40. Grandchamp B, Picat C, Mignotte V et al. (1989) Tissue-specific splicing mutation in acute intermittent porphyria. Proc Natl Acad Sci USA 86: 661–664PubMedCrossRefGoogle Scholar
  41. Khanderia U (1986) Circulatory collapse associated with hemin therapy for acute intermittent porphyria. Clin Pharmacol 5: 690–692Google Scholar
  42. McColl KEL, Moore MR (1981) The acute porphyrias — an example of pharmagenetic disease. Scott Med J 26: 3240Google Scholar
  43. McColl KEL, Moore MR, Thompson GG et al. (1982) Screening for latent acute intermittent porphyria: the value of measuring both leucocyte S-aminolaevulinic acid synthase and erythrocyte uroporphyrinogen-1-synthase activities. J Med Genet 19: 271–276PubMedCrossRefGoogle Scholar
  44. Moore MR (1980) International review of drugs in acute porphyria. J Biochem 12: 1089–1097Google Scholar
  45. Mustajoki P, Heinonen J (1980) General anesthesia in inducible prophyrias. Anesthesiology 53: 15–21PubMedCrossRefGoogle Scholar
  46. Corey TJ, DeLeo VA, Christianson H et al. (1980) Variegate porphyria. Clinical and laboratory features. J Am Acad Dermatol 2: 36–43Google Scholar
  47. Day RS, Eales L, Meissner D (1982) Coexistent variegate porphyria and porphyria cutanea tarda. N Engl J Med 307: 36–41PubMedCrossRefGoogle Scholar
  48. Deybach J, Verneuil H de, Nordmann Y (1981) The inherited enzymatic defect in porphyria variegata. Hum Genet 58: 425–428PubMedCrossRefGoogle Scholar
  49. Fromke VL, Bossenmaier J, Cardinal R et al. (1982) Porphyria variegata. Study of a large kindred in the United States. Am J Med 65: 80–88Google Scholar
  50. Hofmann C, Schmidt D, Braun-Falco 0 (1975) Zur Porphyria variegata. Munch Med Wochenschr 117: 1969–1974Google Scholar
  51. Kramer S (1980) Porphyria variegata. Clin Haematol 9: 303–322PubMedGoogle Scholar
  52. Viljoen DJ, Cummins R, Alexopoulus J et al. (1983) Protoporphyrinogen oxidase and ferrochelatase in porphyria variegata. Eur J Clin Invest 13: 283–287PubMedCrossRefGoogle Scholar
  53. Benedetto AV, Kushner JP, Taylor JS et al. (1978) Porphyria cutanea tarda in three generations of a single family. N Engl J Med 258: 358–362CrossRefGoogle Scholar
  54. Elder GH, Lee GB, Tovey JA (1978) Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda. N Engl J Med 299: 274–278PubMedCrossRefGoogle Scholar
  55. Elder GH, Urguhart AJ, Salamanca RE de et al. (1985) Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda. Lancet II: 229–232Google Scholar
  56. Goerz G, Strohmeyer H (1983) Porphyria cutanea tarda ( PCT ). Internist 24: 543–549Google Scholar
  57. Goerz G, Merk H (1985) Porphyria cutanea tarda. Z Hautkr 60: 137–146PubMedGoogle Scholar
  58. Harber LC, Bickers DR (1984) Porphyria and pseudoporphyria. J Invest Dermatol 82: 207–209PubMedCrossRefGoogle Scholar
  59. Kuntz BME, Goerz G, Merk H et al. (1984) HLA-A3 and -B7 in porphyria cutanea tarda. Tissue Antigens 24: 67–69PubMedCrossRefGoogle Scholar
  60. Meurer M, Schulte C, Weiler A (1985) Photodynamic action of uroporphyrin on the complement system in porphyria cutanea tarda. Arch Dermatol Res 277: 293–298PubMedCrossRefGoogle Scholar
  61. Sweeney GD (1986) Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases. Clin Biochem 19: 3–15PubMedCrossRefGoogle Scholar
  62. Verneuil H de, Beaumont C, Deybach JC et al. (1984) Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial prophyria cutanea tarda and hepatoerythropoietic porphyria. Am J Hum Genet 36: 613–622Google Scholar
  63. Elder GH, Evans JO, Thomas N et al. (1976) The primary enzyme defect in hereditary coproporphyria. Lancet II: 1217–1219Google Scholar
  64. Hunter JAA, Khan A, Hope E et al. (1971) Hereditary coproporphyria. Photosensitivity, jaundice and neuropsychiatrie manifestations associated with pregnancy. Br J Dermatol 84: 301–310Google Scholar
  65. Roberts DJ, Brodie MJ, Moore MR et al. (1977) Hereditary coproporphyria presenting with photosensitivity induced by the contraceptive pill. Br J Dermatol 96: 549–554PubMedCrossRefGoogle Scholar
  66. Topi GC, D’Allessandro Gandolfo L, Fazio M et al. (1977) Coproporphyrie érythropoiétique congénitale observée chez un frère et une soeur. ( Nouvelle forme de corproporphyrie érythropoiétique héréditaire ). Ann Dermatol Venereol 104: 68–70Google Scholar
  67. Elder GH, Smith SE, Herrero C (1981) Hepato-erythropoietic porphyria presenting a new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda. Lancet II: 916–919Google Scholar
  68. Herrero C et al. (1982) Characterization of hepatoerythropoietic porphyria. In: Mascaro J (ed) Porphyrias. Garsi, Madrid, pp 29–36Google Scholar
  69. Hönigsmann H, Reichel K (1979) Hepatoerythrozytäre Porphyrie. Hautarzt 30: 95–97PubMedGoogle Scholar
  70. Piiïol-Aguadé J, Herrero C, Almeida J et al. (1975) Porphyrie hépato-erythrocytaire. Une nouvelle forme de porphyrie. Ann Dermatol Syphiligr 102: 129–136Google Scholar
  71. Toback AC, Sassa S, Poh-Fitzpatrick MB et al. (1987) Hepato-erythropoietic porphyria: clinical, biochemical, and enzymatic studies in a three-generation family lineage. N Engl J Med 316: 645–656PubMedCrossRefGoogle Scholar
  72. Verneuil H de, Beaumont C, Deybach JC et al. (1984) Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria. Am J Hum Genet 36: 613–622PubMedGoogle Scholar
  73. Ashton RE, Hawk JLM, Magnos IA (1984) Low-dose oral chloroquine in the treatment of porphyria cutanea tarda. Br J Dermatol 111: 609–613PubMedCrossRefGoogle Scholar
  74. Bickers DR (1981) Treatment of the porphyrias: mechanisms of action. J Invest Dermatol 77: 107–113PubMedCrossRefGoogle Scholar
  75. Bickers DR, Merk H (1986) Treatment of porphyrias. Semin Dermatol 5: 186–197Google Scholar
  76. Felsher BF, Redeker AG (1966) Effect of chloroquine on hepatic uroporphyrin metabolism in patients with porphyria cutanea tarda. Medicine (Baltimore) 45: 575–583CrossRefGoogle Scholar
  77. Goerz G, Bolsen K, Merk H (1985) Influence of chloroquine on the porphyrin metabolism. Arch Dermatol Res 277: 114–117PubMedCrossRefGoogle Scholar
  78. Ippen H (1961) Allgemeinsymptome der späten Hautporphyrie (porphyria cutanea tarda) als Hinweise für deren Behandlung. Dtsch Med Wochenschr 86: 127–133PubMedCrossRefGoogle Scholar
  79. Ippen H (1977) Treatment of porphyria cutanea tarda by phlebotomy. Semin Hematol 14: 253–259PubMedGoogle Scholar
  80. Kordac V, Papézovâ R,Semrâdovâ M (1977) Chloroquine in the treatment of porphyria cutanea tarda. N Engl J Med 296: 949Google Scholar
  81. Marchesi L, DiPadova C, Cainelli T et al. (1984) A comparative trial of desferrioxamine and hydroxychloroquine for treatment of porphyria cutanea tarda in alcoholic patients. Photodermatol 1: 286–292PubMedGoogle Scholar
  82. Rocchi E, Gibertini P, Cassanelli M et al. (1986) Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion. Br J Dermatol 114: 621–629PubMedCrossRefGoogle Scholar
  83. Salamanica RE de, Pena ML, Olmos A et al. (1980) Follow-up studies of porphyrin excretion in porphyria cutanea tarda treated with p-aminobenzoic acid. Am Clin Res 12: 279Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • Otto Braun-Falco
    • 1
  • Gerd Plewig
    • 2
  • Helmut H. Wolff
    • 3
  • Richard K. Winkelmann
    • 4
  1. 1.Dermatologische Klinik und PoliklinikLudwig-Maximilians-Universität MünchenMünchen 2Federal Republic of Germany
  2. 2.Hautklinik der Heinrich-Heine-UniversitätDüsseldorfFederal Republic of Germany
  3. 3.Klinik für Dermatologie und VenerologieMedizinischen Universität zu LübeckLübeck 1Federal Republic of Germany
  4. 4.Dermatology — Dermatopathology, Mayo ClinicMayo Medical SchoolRochesterUSA

Personalised recommendations